vimarsana.com

Page 50 - ஒன்றுபட்டது மாநிலங்களில் மையங்கள் க்கு நோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

British variant of COVID-19 not as severe as feared - The Lancet

By Reuters Staff 2 Min Read FILE PHOTO: The word COVID-19 is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration (Reuters) -A highly contagious variant of COVID-19 first identified in Britain does not cause more severe disease in hospitalised patients, according to a new study published in the medical journal The Lancet Infectious Diseases on Monday. The strain, known as B.1.1.7, was identified in Britain late last year and has become the most common strain in the United States, according to the United States Centers for Disease Control and Prevention. The study analysed a group of 496 COVID-19 patients who were admitted to British hospitals in November and December last year, comparing outcomes in patients infected with B.1.1.7 or other variants. The researchers found no difference in risks of severe disease, death, or other clinical outcomes in patients with B.1.1.7 and other variants.

Coronavirus: UAE reports 2,022 Covid-19 cases, 1,731 recoveries, 4 deaths

Coronavirus: UAE reports 2,022 Covid-19 cases, 1,731 recoveries, 4 deaths Web report/Dubai Over 40.4 million tests have been conducted across the country to date. The UAE Ministry of Health and Prevention on Tuesday reported 2,022 cases of the Covid-19 coronavirus, along with 1,731 recoveries and 4 deaths. The new cases were detected through 266,023 additional tests. Over 40.6 million tests have been conducted across the country to date. The total number of cases in UAE as on April 13 are 487,697, while total recoveries stand at 471,906. The death toll rises to 1,537. A highly contagious variant of Covid-19 first identified in Britain does not cause more severe disease in hospitalised patients, according to a new study published in the medical journal The Lancet Infectious Diseases on Monday.

Health Canada investigating blood clot reports after U S pauses J&J vaccine

Philippine vaccine experts looking into mixing of COVID-19 vaccine brands

Johnson & Johnson delays rollout of its vaccine in Europe

Johnson & Johnson delays rollout of its vaccine in Europe Specialists are reviewing data on possible connection between the use of the vaccine and formation of blood clots © EPA-EFE/ETIENNE LAURENT MOSCOW, April 13. /TASS/. Johnson & Johnson has postponed the use of its vaccine in European countries following reports about the jab’s possible connection to the formation of blood clots, the company said in a press release on Tuesday. Read also The company notes that the decision was made after the recommendation of American regulators to suspend the use of the drug in the United States due to the possible side effects that the vaccine can cause. In particular six cases of formation of blood clots post-vaccination were registered in the country.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.